Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

NCT02118831 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Age-related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion

Interventions

BIOLOGICAL: Blood Sample Collection
DRUG: Aflibercept
DRUG: Bevacizumab
DRUG: Ranibizumab

Sponsor

California Retina Consultants